23andMe proprietor Anne Wojcicki talks all through a House Committee on Oversight and Government Reform listening to in Washington, D.C., on June 10, 2025.
Andrew Harnik|Getty Images
Anne Wojcicki, the founder and former chief govt officer of 23andMe, has really restored management over the embattled hereditary screening agency after her brand-new not-for-profit, TTAM Research Institute, outbid Regeneron Pharmaceuticals, the agencyannounced Friday
TTAM will definitely receive considerably each one among 23andMe’s possessions for $305 million, together with its Personal Genome Service and Research Services service traces along with telehealth subsidiaryLemonaid Health It’s an enormous win for Wojcicki, that tipped down from her operate as chief govt officer when 23andMe declared Chapter 11 insolvency protection in March.
Last month, Regeneron launched it might actually purchase quite a lot of 23andMe’s possessions for $256 million after it triumphed all through a private chapter public public sale. But Wojcicki despatched a unique $305 million quote by way of TTAM and pressed to renew the general public public sale. TTAM is a phrase for the preliminary letters of 23andMe, in accordance with The Wall Street Journal.
“I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome,” Wojcicki acknowledged in a declaration.
23andMe acquired enchantment as a consequence of its at-home DNA screening units that provided shoppers understanding proper into their relations backgrounds and hereditary accounts. The five-time Disruptor 50 agency went public in 2021 utilizing a merging with an distinctive goal procurement agency. At its top, 23andMe was valued at round $6 billion.
The agency battled to supply persisting earnings and stand sensible analysis research and therapies companies after going public, and it has really been suffering from private privateness points provided that hackers accessed the information of virtually 7 million shoppers in 2023.
TTAM’s procurement continues to be primarily based on authorization by the united state Bankruptcy Court for the Eastern District of Missouri.
